세계의 국소 지혈제 시장 : 제품, 제제, 용도, 최종 용도별 예측(2025-2030년)

The Topical Hemostat Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.26 billion in 2024, and is projected to grow at a CAGR of 6.80%, to USD 3.36 billion by 2030.

Topical Hemostats are pivotal in managing bleeding during surgical procedures by accelerating the body's natural clotting process. The scope of topical hemostats spans various sectors including hospitals, clinics, and ambulatory surgical centers, where they serve as critical tools for minimizing intraoperative and postoperative bleeding. Their necessity is underscored by their effectiveness in reducing surgical complications and improving patient outcomes. Key applications involve surgical procedures across cardiovascular, reconstructive, orthopedic, and trauma surgeries. The market is propelled by factors such as the rising incidence of surgeries, increasing prevalence of bleeding disorders, and advancements in hemostatic products. There is a significant opportunity in developing advanced hemostat formulations that combine ease of use with enhanced efficacy, such as time-release formulations and biodegradable options, to cater to diverse surgical needs. Furthermore, emerging markets present untapped potential due to increasing healthcare expenditure and infrastructure development. However, market growth is challenged by factors such as stringent regulatory requirements, potential product recalls, and high costs associated with advanced hemostatic devices. To capture market opportunities, businesses should focus on innovation in product development emphasizing faster hemostatic response and minimal adverse reactions. Additionally, exploring collaborative ventures with healthcare institutions for R&D and leveraging digital marketing strategies could enhance market penetration. The nature of this market is highly competitive and driven by technological advancements, necessitating continuous investment in R&D to stay ahead. Breaking into niche markets and exploring combination products, like those pairing hemostats with antibiotics to reduce infection risks, could offer a distinct advantage. Overall, focused research on cost-effective, sustainable, and multi-functional hemostatic agents could significantly boost market growth and address key clinical demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Hemostat Market

The Topical Hemostat Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
  • Favorable product approval by medical regulators
• Market Restraints
  • High costs associated with topical hemostat products
• Market Opportunities
  • Ongoing R&D for the introduction of novel topical hemostat
  • Integration of nanotechnology to create more efficient topical hemostats
• Market Challenges
  • Operational limitations and risk of infection associated with the use of topical hemostats

Porter's Five Forces: A Strategic Tool for Navigating the Topical Hemostat Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Hemostat Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Hemostat Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Hemostat Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Hemostat Market

A detailed market share analysis in the Topical Hemostat Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Hemostat Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Hemostat Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Hemostat Market

A strategic analysis of the Topical Hemostat Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Hemostat Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Betatech Medical, BioCer Entwicklungs-GmbH, Bristol-Myers Squibb Company, Dilon Technologies Inc, GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Marine Polymer Technologies, Inc., Medline Industries, LP, Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer Inc., Southmedic Inc., Stryker Corporation, SYMATESE SAS, Takeda Pharmaceutical Company Limited, Teleflex Incorporated, and Zeria Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats, Oxidized Regenerated Cellulose-based Topical Hemostats, and Thrombin-Based Topical Hemostats.
• Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats.
• Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Liver & Spleen Lacerations, Orthopedic Surgery, and Reconstructive Surgery.
• Based on End-Use, market is studied across Hospitals, Nursing Homes, and Surgical Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
    • 5.1.1.2. Favorable product approval by medical regulators
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with topical hemostat products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
    • 5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
  • 5.1.4. Challenges
    • 5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
  • 5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
  • 5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
  • 5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Topical Hemostat Market, by Product

• 6.1. Introduction
• 6.2. Collagen-Based Topical Hemostats
• 6.3. Combination Topical Hemostats
• 6.4. Gelatin-Based Topical Hemostats
• 6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
• 6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Formulation

• 7.1. Introduction
• 7.2. Matrix & Gel Hemostats
• 7.3. Powder Hemostats
• 7.4. Sheet & Pad Hemostats
• 7.5. Sponge Hemostats

8. Topical Hemostat Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular Surgery
• 8.3. General Surgery
• 8.4. Liver & Spleen Lacerations
• 8.5. Orthopedic Surgery
• 8.6. Reconstructive Surgery

9. Topical Hemostat Market, by End-Use

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Nursing Homes
• 9.4. Surgical Centers

10. Americas Topical Hemostat Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Topical Hemostat Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Topical Hemostat Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
  • 13.3.2. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
  • 13.3.3. Hemostasis Closes Acquisition of Fiagon Medical Technologies
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aegis Lifesciences Private Limited
• 2. Axio Biosolutions Pvt Ltd
• 3. B.Braun Melsungen AG
• 4. Baxter International, Inc.
• 5. Becton, Dickinson and Company
• 6. Betatech Medical
• 7. BioCer Entwicklungs-GmbH
• 8. Bristol-Myers Squibb Company
• 9. Dilon Technologies Inc
• 10. GELITA MEDICAL GmbH
• 11. Hemostasis, LLC
• 12. Integra LifeSciences Corporation
• 13. Johnson & Johnson Services, Inc.
• 14. Marine Polymer Technologies, Inc.
• 15. Medline Industries, LP
• 16. Medtrade Products Ltd
• 17. Medtronic PLC
• 18. Meril Life Sciences Pvt. Ltd
• 19. Pfizer Inc.
• 20. Southmedic Inc.
• 21. Stryker Corporation
• 22. SYMATESE SAS
• 23. Takeda Pharmaceutical Company Limited
• 24. Teleflex Incorporated
• 25. Zeria Pharmaceutical Co., Ltd.